☰

Conan G. Kinsey, Ph.D. - Publications

Affiliations: 
2010 University of Rochester, Rochester, NY 
Area:
Genetics
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ghazi PC, O'Toole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G, Flynn DL, Snyder EL, Kinsey CG, McMahon M. Inhibition of ULK1/2 and KRAS controls tumor growth in preclinical models of lung cancer. Biorxiv : the Preprint Server For Biology. PMID 38370808 DOI: 10.1101/2024.02.06.579200  0.374
2021 Foth M, Garrido-Laguna I, Kinsey CG. Therapeutic Targeting of Autophagy in Pancreatic Cancer. Surgical Oncology Clinics of North America. 30: 709-718. PMID 34511191 DOI: 10.1016/j.soc.2021.06.001  0.324
2020 Truong A, Yoo JH, Scherzer M, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi P, Onken MD, Blumer KJ, Odelberg SJ, McMahon M. Chloroquine sensitizes GNAQ/11-mutated melanoma to MEK1/2 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32933997 DOI: 10.1158/1078-0432.Ccr-20-1675  0.468
2020 Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M. Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Reports. 32: 107994. PMID 32755586 DOI: 10.1016/J.Celrep.2020.107994  0.453
2020 Rahib L, Chen K, Ocean AJ, Xie C, Duffy A, Manji GA, Greten TF, Shapiro M, Shrager J, Hoos W, Federowicz B, Kinsey CG. Use of a real-world data approach to rapidly generate outcomes data following a case study of a novel treatment combination in pancreatic adenocarcinoma. Journal of Clinical Oncology. 38: e16735-e16735. DOI: 10.1200/Jco.2020.38.15_Suppl.E16735  0.327
2020 Vaishnavi A, Scherzer MT, Kinsey C, Garrido-Laguna I, McMahon M. Abstract 3769: Combined TRKA and MEK1/2 Inhibition Forestalls the Onset of Acquired Resistance in a New Preclinical Model of NTRK1+ Pancreatic Cancer Immunology. 80: 3769-3769. DOI: 10.1158/1538-7445.Am2020-3769  0.536
2019 Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW, Cavalieri CC, et al. Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nature Medicine. PMID 30918364 DOI: 10.1038/S41591-019-0433-3  0.307
2019 Kinsey CG, Camolotto SA, Boespflug AM, Gullien KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW, Cavalieri CC, et al. Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nature Medicine. PMID 30833748 DOI: 10.1038/S41591-019-0367-9  0.58
2019 Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW, Cavalieri CC, et al. Abstract 2183: Protective autophagy elicited by RAF®MEK®ERK inhibition suggests a treatment strategy for pancreatic cancer Cancer Research. 79: 2183-2183. DOI: 10.1158/1538-7445.Am2019-2183  0.499
2018 Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S. Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. Journal of Gastrointestinal Oncology. 9: 1014-1026. PMID 30603120 DOI: 10.21037/Jgo.2018.05.16  0.34
2018 Kinsey C, Guillen K, Camolotto S, Boespflug A, Shea J, Seipp M, Scaife C, McMahon M. Abstract LB-254: Combined inhibition of MEK and autophagy promotes regression of pancreatic cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-254  0.576
2014 Kinsey C, Balakrishnan V, O'Dell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Reports. 7: 1143-55. PMID 24794439 DOI: 10.1016/J.Celrep.2014.03.061  0.561
2008 McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature. 453: 1112-6. PMID 18500333 DOI: 10.1038/Nature06973  0.539
Show low-probability matches.